I have a bit of a sweet tooth. When I was little, my dad used to buy me those massive 64-ounce Jelly Belly containers from Costco. Even that wasn’t…
AQS.V
Aequus Pharmaceuticals(“AQS”) a specialty pharmaceutical company that develops and focuses on commercializing value-added products in specialty therapeutic areas in the Canadian market is today EG idea of the day….
This episode is all about Aequus Pharmaceuticals Inc. (AQS.V), a specialty pharmaceutical company, develops and commercializes drugs in Canada. It focuses on various therapeutic areas, including neurology, ophthalmology, and…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Aequus Pharmaceuticals (AQS.V) is a growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Aequus has grown its sales and marketing efforts to include several commercial…
Aequus Pharmaceuticals (AQS.V) is a growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Aequus has grown its sales and marketing efforts to include several…
On May 31, 2021 Aequus Pharmaceuticals (AQS.V) reported financial results for Q1, 2021. Aequus is a $19 million pharmaceutical company focused on developing and commercializing high quality, differentiated…
Aequus is a $24 million pharmaceutical company focused on developing and commercializing high quality, differentiated products….
Developing new prescription medicine for market is a costly and oftentimes, a futile endeavor as drugmakers can spend up to $2.6 billion only to see 12% of their candidates…
Currently in Canada, the dry eye market is estimated at over $9O million, which includes both prescription and over-the-counter products….